DJIA 15,302.80 -15.43 -0.10%
NASDAQ 3,476.23 -5.95 -0.17%
S&P 500 1,649.24 -2.57 -0.16%
market minute promo

company name or ticker

Positive Data from Synergy Pharma - Analyst Blog

Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide

Synergy Pharma Posts Wider Loss - Analyst Blog

Bearish MACD for Synergy Pharmaceuticals Inc. - Tale of the Tape

Synergy On Sale: Why This Opportunity Shouldn't Be Missed

Synergy Pharmaceuticals Becomes Oversold (SGYP)

Synergy Pharma Reports Completion of Public Offering of Shares, Received Net Proceeds $84.5M

This Week in Biotech

A "breakthrough therapy" designation, an accelerated new drug application go-ahead from the Food and Drug Administration, and plenty of analyst upgrades dominated the biotech scene this week.

Synergy Pharma Prices Public Offering - Analyst Blog

Synergy Pharmaceuticals Prices 16.375M Share Public Offering at $5.50/Share